Results 191 to 200 of about 475,040 (341)

Nanotechnology-driven advances in intranasal vaccine delivery systems against infectious diseases. [PDF]

Front Immunol
Zhang Z, Yang Y, Huang L, Yuan L, Huang S, Zeng Z, Cao Y, Wei X, Wang X, Shi M, Zhong M.   +10 more
europepmc   +1 more source

Multicenter observational study to characterize fibroblast growth factor receptor 2 fusions or rearrangements in patients with advanced/metastatic cholangiocarcinoma

Hepatology Research, EarlyView.
In this study, we assessed patients with cancer of the liver bile ducts (intrahepatic cholangiocarcinoma) or cancer in bile ducts just outside the liver (perihilar cholangiocarcinoma) to see what factors were most commonly found in patients with fusions (and/or rearrangements) of the FGFR2 gene, a prominent target in bile duct cancer. Overall, we found
Tomoyuki Satake, Chigusa Morizane, Hiroyuki Isayama, Akio Katanuma, Masato Endo, Noritoshi Kobayashi, Yasushi Kojima, Shoji Kubo, Saburo Matsubara, Takeshi Shiraishi, Takashi Ohta, Tadashi Uwagawa, Shingo Kobayashi, Takatoshi Sahara, Setsuo Funasaka, Hiroki Ikezawa, Takuji Okusaka   +16 more
wiley   +1 more source

Drug development for chronic hepatitis B functional cure: Recent progress. [PDF]

World J Hepatol
Liu T, Wang H, Zhao Y, Wang YX, Xing X, Gao P.   +5 more
europepmc   +1 more source

Characterization of hepatitis B virus surface antigen produced in yeast.

, 1987
Keishin Sugahara, Hiroyuki Yokote, Koichi Shiosaki, Satoshi Adachi, Kazumasa Miyata, Yoshinobu Miyatsu, Chikateru Nozaki, Hiroshi Mizokami, F. Miake, F Hamada   +9 more
openalex   +2 more sources

Genetic alterations in hepatocellular carcinoma after sustained virological response in relation to the molecular characterization of metabolic diseases

Hepatology Research, EarlyView.
Hepatocellular carcinoma (HCC) in the hepatitis C virus (HCV)‐sustained virologic response (SVR) group was associated with alcohol consumption and metabolic diseases and showed significantly lower rates of ARID2 alterations and AXIN1 alterations compared to the HCV‐non‐SVR group, with a mutational profile resembling that of the steatotic liver disease ...
Fukiko Kawai‐Kitahata, Yasuhiro Asahina, Sei Kakinuma, Kento Inada, Tomohiro Mochida, Keiya Watakabe, Tsubasa Nobusawa, Taro Shimizu, Jun Tsuchiya, Masato Miyoshi, Shun Kaneko, Miyako Murakawa, Sayuri Nitta, Mina Nakagawa, Yuko Kinowaki, Daisuke Ban, Shinji Tanaka, Tatsuhiko Anzai, Shinichi Takano, Shinya Maekawa, Nobuyuki Enomoto, Ryuichi Okamoto   +21 more
wiley   +1 more source

Anti-HBs persistence and anamnestic response among medical interns vaccinated in infancy. [PDF]

Sci Rep
Hanafi NF, Omar NN, Ismail GA, El-Kholy AA, ElShafei A, Essa SA.   +5 more
europepmc   +1 more source

Extrahepatic malignancy following long-term immunosuppressive therapy of severe hepatitis B surface antigen-negative chronic active hepatitis [PDF]

, 1989
Kenneth K. Wang, Albert J. Czaja, Sandra J. Beaver, Vay Liang W. Go   +3 more
openalex   +1 more source

Predicting the risk of developing diabetes in steatotic liver disease using controlled attenuation parameter in a health checkup population

Hepatology Research, EarlyView.
Higher amounts of liver fat, measured noninvasively using the controlled attenuation parameter (CAP), are a strong predictor of the future development of type 2 diabetes mellitus. The risk increases in proportion to the increase in CAP. Measuring CAP could help identify individuals who need diabetes prevention strategies.
Takuma Nakatsuka, Yutaka Yamaji, Ryosuke Tateishi, Takako Ogasawara, Rena Mihara, Yoshiaki Kawashima, Tetsuharu Ono, Tomoharu Yamada, Tatsuya Minami, Masaya Sato, Takeshi Hayashi, Yuki Matsushita, Kazuyoshi Funato, Tatsuya Sato, Tomotaka Saito, Yotaro Kudo, Hirofumi Kogure, Hayato Nakagawa, Yoshinari Asaoka, Yasuo Tanaka, Yousuke Nakai, Hideaki Ijichi, Mitsuhiro Fujishiro   +22 more
wiley   +1 more source

Identification of B cell antigens in solid cancer: initial insights and functional implications. [PDF]

Front Immunol
Yang JI, Moresco P, Fearon D, Yao M.
europepmc   +1 more source

Cytomegalovirus serostatus among people with HIV, characterizing the prevalence, risk factors, and association with immune recovery

HIV Medicine, EarlyView.
Abstract Introduction Cytomegalovirus (CMV) infection is common among people with HIV (PWH), and may be associated with negative outcomes. We aimed to identify the seroprevalence of CMV between 01 January 1998 and 01 June 2022 among PWH accessing care at the Southern Alberta Clinic (SAC) and the associated risk factors.
Joshua Quisias, M. John Gill, Sally B. Coburn, Hartmut B. Krentz, Brenda Beckthold, Kevin Fonseca, Michael D. Parkins, Raynell Lang   +7 more
wiley   +1 more source